SEATTLE GENETICS INC's ticker is SGENXXXX and the CUSIP is 812578102. A total of 490 filers reported holding SEATTLE GENETICS INC in Q2 2020. The put-call ratio across all filers is 0.72 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2020 | $2,783,000 | +106.5% | 24,121 | +31.1% | 0.03% | +266.7% |
| Q1 2019 | $1,348,000 | -89.1% | 18,402 | -88.5% | 0.01% | -83.9% |
| Q3 2018 | $12,326,000 | +92.1% | 159,834 | +65.4% | 0.06% | +93.1% |
| Q2 2018 | $6,415,000 | +723.5% | 96,620 | +548.9% | 0.03% | +866.7% |
| Q1 2018 | $779,000 | +159.7% | 14,890 | +165.9% | 0.00% | +200.0% |
| Q4 2017 | $300,000 | -67.4% | 5,600 | -66.9% | 0.00% | -75.0% |
| Q3 2017 | $920,000 | +10.8% | 16,900 | +28.0% | 0.00% | 0.0% |
| Q1 2017 | $830,000 | -87.4% | 13,200 | -89.4% | 0.00% | -88.6% |
| Q4 2016 | $6,596,000 | -65.0% | 125,000 | -64.2% | 0.04% | -67.9% |
| Q3 2016 | $18,842,000 | +19.6% | 348,864 | -10.5% | 0.11% | +6.9% |
| Q2 2016 | $15,760,000 | +248.1% | 390,000 | +202.3% | 0.10% | +277.8% |
| Q1 2016 | $4,527,000 | – | 129,000 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Baker Brothers Advisors | 44,100,294 | $2,381,857,000 | 21.61% |
| Lagoda Investment Management, L.P. | 567,057 | $30,627,000 | 9.21% |
| Redmile Group, LLC | 1,781,470 | $96,217,000 | 7.65% |
| Boxer Capital, LLC | 232,600 | $12,563,000 | 5.63% |
| NEXTHERA CAPITAL LP | 111,500 | $6,022,000 | 3.70% |
| Eventide Asset Management | 835,506 | $45,126,000 | 2.76% |
| WASATCH ADVISORS LP | 2,844,908 | $153,653,000 | 2.29% |
| Opus Point Partners Management, LLC | 67,953 | $3,670,000 | 2.06% |
| CORRADO ADVISORS, LLC | 43,050 | $2,325,000 | 1.48% |
| Baillie Gifford | 16,795,793 | $907,142,000 | 1.42% |